Data as of Jul 22
| +0.05 / +0.81%|
The 3 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +28.41% increase from the last price of 6.23.
The current consensus among 3 polled investment analysts is to Hold stock in Sucampo Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.